CDKN2A and central nervous system cancer: We used the Ntv-a Arf-/- mice and induced tumors with RCAS-PDGF-B, a combination that mainly produces high-grade gliomas [27] and analyzed how simultaneous expression of HRG would affect brain tumor development.